eLaws | eCases | State of Washington |
 Washington Administrative Code (Last Updated: November 23, 2016)
 Title 296. Labor and Industries, Department of
 Chapter 296-823. Occupational exposure to bloodborne pathogens.

  Section 296-823-180. Additional requirements for HIV and HBV research laboratories and production facilities.  

Latest version.
  • Summary
    Your responsibility:
    To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV.
    EXEMPTION:
    This section does NOT apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs.
    Note:
    Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (bloodborne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities.
    [Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050. WSR 15-23-086, § 296-823-180, filed 11/17/15, effective 12/18/15. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; WSR 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.]
RCW 49.17.010, 49.17.040, 49.17.050. WSR 15-23-086, § 296-823-180, filed 11/17/15, effective 12/18/15. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; WSR 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.